Tacrolimus Range

Tacrolimus PCD Pharma Franchise Company

Cafoli Lifecare is a WHO-GMP certified pharmaceutical company offering 10 Tacrolimus formulations for PCD pharma franchise, distributors and monopoly marketing partners across India. The range spans oral capsules and tablets and topical creams, gels and eye ointments.

What is Tacrolimus?

Tacrolimus is a calcineurin-inhibitor immunosuppressant. Oral forms are used to prevent organ-transplant rejection, while topical forms treat atopic dermatitis and certain inflammatory skin and eye conditions. Oral therapy requires specialist supervision and drug-level monitoring. Reference: PubChem.

Available Tacrolimus Formulations

Cafoli Lifecare's Tacrolimus portfolio is available as Capsule, Tablet, Cream, Gel and Eye Ointment, serving transplant, dermatology and ophthalmology prescribing from a single supplier.

Therapeutic Applications

Oral Tacrolimus is used to prevent rejection after kidney, liver and other organ transplants; topical Tacrolimus is used for moderate-to-severe atopic dermatitis and allergic eye disease. It is prescribed by nephrologists, transplant physicians, dermatologists and ophthalmologists.

Why Tacrolimus is a High-Potential Molecule for Distributors

Tacrolimus serves two durable niches — lifelong transplant immunosuppression and a large dermatology market for steroid-sparing eczema therapy. Both are specialist-driven and price-stable, making Tacrolimus a differentiated, high-value addition for franchise partners targeting nephrology and derma segments.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers monopoly (district-wise) distribution rights, WHO-GMP and DCGI-approved manufacturing, attractive net rates, complete promotional inputs (visual aids, MR bags, product cards) and prompt dispatch — trusted by 1000+ franchise partners across India.

References

1. PubChem – Tacrolimus
2. PubMed – Tacrolimus literature